litlas
Log inCreate account

Michael J. Rogers

Active 1972–2021

Also published as
Michael J Rogers
98
Papers
24,153
Citations
84
h-index
98
i10-index

Citations

Citations per year for Michael J. Rogers1948: 1 citations1973: 5 citations1974: 18 citations1975: 25 citations1976: 26 citations1977: 19 citations1978: 14 citations1979: 23 citations1980: 19 citations1981: 15 citations1982: 9 citations1983: 2 citations1984: 7 citations1985: 10 citations1986: 9 citations1987: 3 citations1988: 7 citations1989: 20 citations1990: 13 citations1991: 14 citations1992: 16 citations1993: 25 citations1994: 21 citations1995: 19 citations1996: 31 citations1997: 43 citations1998: 67 citations1999: 131 citations2000: 142 citations2001: 178 citations2002: 174 citations2003: 201 citations2004: 215 citations2005: 185 citations2006: 240 citations2007: 205 citations2008: 217 citations2009: 239 citations2010: 254 citations2011: 261 citations2012: 168 citations2013: 136 citations2014: 129 citations2015: 120 citations2016: 117 citations2017: 134 citations2018: 110 citations2019: 460 citations2020: 548 citations2021: 438 citations2022: 324 citations2023: 220 citations2024: 317 citations2025: 131 citations2026: 4 citations1949–1972: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,649 citing papers, 26.2% of this breakdownUnited Kingdom: 541 citing papers, 8.6% of this breakdownChina: 506 citing papers, 8.1% of this breakdownGermany: 317 citing papers, 5% of this breakdownAustralia: 288 citing papers, 4.6% of this breakdownItaly: 272 citing papers, 4.3% of this breakdownJapan: 256 citing papers, 4.1% of this breakdownFrance: 248 citing papers, 3.9% of this breakdownCanada: 202 citing papers, 3.2% of this breakdownSwitzerland: 200 citing papers, 3.2% of this breakdownNetherlands: 153 citing papers, 2.4% of this breakdownSpain: 142 citing papers, 2.3% of this breakdown
0%26.2%Other 24.1%

Institutions

Fields

  • Medicine54.4%
  • Biochemistry, Genetics and Molecular Biology28.2%
  • Immunology and Microbiology6.9%
  • Engineering2.3%
  • Dentistry1.9%
  • Neuroscience1.3%
  • Other5%

Topics

  • Bone health and treatments11.7%
  • Bone Metabolism and Diseases6.4%
  • Bone health and osteoporosis research5%
  • Bone and Joint Diseases3.8%
  • Malaria Research and Control1.8%
  • Radiopharmaceutical Chemistry and Applications1.7%
  • Other69.6%

Coauthors

All papers

Open in search
  1. Osteoclasts recycle via osteomorphs during RANKL-stimulated bone resorption

    Authors: Michelle M. McDonald, Weng Hua Khoo, Pei Ying Ng, Ya Xiao, Jad Zamerli, Peter Thatcher, Wunna Kyaw, Karrnan Pathmanandavel, Abigail K. Grootveld, Imogen Moran, Danyal Butt, Akira Nguyen, Alexander P. Corr, Sean Warren, Maté Biro, Natalie C. Butterfield, Siobhan E. Guilfoyle, Davide Komla‐Ebri, Michael R.G. Dack, Hannah F. Dewhurst, John G. Logan, Yongxiao Li, Sindhu T. Mohanty, Niall Byrne, Rachael Terry, Marija K. Simic, Ryan C. Chai, Julian M.W. Quinn, Scott E. Youlten, Jessica A. Pettitt, David Abi‐Hanna, Rohit Jain, Wolfgang Weninger, Mischa Lundberg, Shuting Sun, Frank H. Ebetino, Paul Timpson, Woei Ming Lee, Paul A. Baldock, Michael J. Rogers, Robert Brink, Graham R. Williams, J. H. Duncan Bassett, John P. Kemp, Nathan J. Pavlos, Peter I. Croucher, Tri Giang Phan - Cell 2021 cited by 423

  2. Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal niche

    Authors: Michelle A. Lawson, Michelle M. McDonald, Nataša Kovačić, Weng Hua Khoo, Rachael Terry, Jenny Down, Warren Kaplan, Julia Paton‐Hough, Clair Fellows, Jessica A. Pettitt, T. Neil Dear, Els Van Valckenborgh, Paul A. Baldock, Michael J. Rogers, Colby L. Eaton, Karin Vanderkerken, Allison R. Pettit, Julian M.W. Quinn, Andrew C.W. Zannettino, Tri Giang Phan, Peter I. Croucher - Nature Communications 2015 cited by 393

  3. Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy

    Authors: R.G.G. Russell, Nelson B. Watts, Frank H. Ebetino, Michael J. Rogers - Osteoporosis International 2008 cited by 1,392

  4. A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria

    Authors: Margaret A. Phillips, Julie Lotharius, Kennan C. Marsh, John White, Anthony D. Dayan, Karen L. White, Jacqueline W. Njoroge, Farah El Mazouni, Yanbin Lao, Sreekanth Kokkonda, Diana R. Tomchick, Xiaoyi Deng, Trevor Laird, Sangeeta N. Bhatia, Sandra March, Caroline L. Ng, David A. Fidock, Sergio Wittlin, María José Lafuente-Monasterio, Francisco Javier Gamo Benito, Laura Maria Sanz Alonso, Maria Santos Martínez, Marı́a Belén Jiménez-Dı́az, Santiago Ferrer, Íñigo Angulo‐Barturen, John N. Haselden, James B. Louttit, Yi Cui, Arun Sridhar, Anne‐Marie Zeeman, Clemens H. M. Kocken, Robert W. Sauerwein, Koen J. Dechering, Vicky M. Avery, Sandra Duffy, Michael J. Delves, Robert E. Sinden, Andrea Ruecker, Kristina S. Wickham, Rosemary Rochford, Janet Gahagen, Lalitha Iyer, Ed Riccio, Jon C. Mirsalis, Ian Bathhurst, Thomas Rueckle, Xavier C. Ding, Brice Campo, Didier Leroy, Michael J. Rogers, Pradipsinh K. Rathod, Jeremy N. Burrows, Susan A. Charman - Science Translational Medicine 2015 cited by 375

  5. Molecular mechanisms of action of bisphosphonates and new insights into their effects outside the skeleton

    Authors: Michael J. Rogers, Jukka Mönkkönen, Marcia A. Munoz - Bone 2020 cited by 182

  6. Molecular Mechanisms of Action of Bisphosphonates: Current Status

    Authors: Anke J. Roelofs, Keith Thompson, Sharon Gordon, Michael J. Rogers - Clinical Cancer Research 2006 cited by 567

  7. Phase I Clinical Trial Results of Auranofin, a Novel Antiparasitic Agent

    Authors: Edmund V. Capparelli, Robin Bricker-Ford, Michael J. Rogers, James H. McKerrow, Sharon L. Reed - Antimicrobial Agents and Chemotherapy 2016 cited by 145

  8. Oxysterols: From physiological tuners to pharmacological opportunities

    Authors: Andrew J. Brown, Laura J. Sharpe, Michael J. Rogers - British Journal of Pharmacology 2020 cited by 89

  9. Nitrogen-Containing Bisphosphonates Inhibit the Mevalonate Pathway and Prevent Post-Translational Prenylation of GTP-Binding Proteins, Including Ras

    Authors: Steven P. Luckman, D. E. Hughes, Fraser P. Coxon, R.G.G. Russell, Michael J. Rogers - Journal of Bone and Mineral Research 1998 cited by 1,187

  10. Bone remodelling at a glance

    Authors: Julie C. Crockett, Michael J. Rogers, Fraser P. Coxon, Lynne J. Hocking, Miep Helfrich - Journal of Cell Science 2011 cited by 498

  11. Biochemical and molecular mechanisms of action of bisphosphonates

    Authors: Michael J. Rogers, Julie C. Crockett, Fraser P. Coxon, Jukka Mönkkönen - Bone 2010 cited by 519

  12. Peripheral blood monocytes are responsible for γδ T cell activation induced by zoledronic acid through accumulation of IPP/DMAPP

    Authors: Anke J. Roelofs, Marjo Jauhiainen, Hannu Mönkkönen, Michael J. Rogers, Jukka Mönkkönen, Keith Thompson - British Journal of Haematology 2008 cited by 288

  13. The regulation of osteoclast function and bone resorption by small GTPases

    Authors: Cécile Itzstein, Fraser P. Coxon, Michael J. Rogers - Small GTPases 2011 cited by 153

  14. The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs

    Authors: K.L. Kavanagh, Kunde Guo, James E. Dunford, Xiaoqiu Wu, Stefan Knapp, Frank H. Ebetino, Michael J. Rogers, R.G.G. Russell, Udo Oppermann - National Academy of Sciences, Proceedings of the National Academy of Sciences 2006 cited by 532

  15. Further Insight into Mechanism of Action of Clodronate: Inhibition of Mitochondrial ADP/ATP Translocase by a Nonhydrolyzable, Adenine-Containing Metabolite

    Authors: Petri Lehenkari, Maarit Kellinsalmi, Juha Näpänkangas, Kari Ylitalo, Jukka Mönkkönen, Michael J. Rogers, Alex Azhayev, H. Kalervo Väänänen, Ilmo E. Hassinen - Molecular Pharmacology 2002 cited by 328

  16. The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo

    Authors: Lauren S. Whyte, Erik Ryberg, Natalie A. Sims, Susan A. Ridge, Ken Mackie, Peter J. Greasley, Ruth A. Ross, Michael J. Rogers - National Academy of Sciences, Proceedings of the National Academy of Sciences 2009 cited by 326

  17. Real-Time Intravital Imaging Establishes Tumor-Associated Macrophages as the Extraskeletal Target of Bisphosphonate Action in Cancer

    Authors: Simon Junankar, Gemma Shay, Julie Jurczyluk, Naveid Ali, Jenny Down, Nicholas Pocock, Andrew Parker, Akira Nguyen, Shuting Sun, B. A. Kashemirov, Charles E. McKenna, Peter I. Croucher, Alexander Swarbrick, Katherine N. Weilbaecher, Tri Giang Phan, Michael J. Rogers - Cancer Discovery 2014 cited by 147

  18. Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells

    Authors: Bhavik Desai, Michael J. Rogers, Meenakshi A. Chellaiah - Molecular Cancer 2007 cited by 156

  19. Clodronate and Liposome-Encapsulated Clodronate Are Metabolized to a Toxic ATP Analog, Adenosine 5′-(β,γ-Dichloromethylene) Triphosphate, by Mammalian Cells In Vitro

    Authors: Julie C. Frith, Jukka Mönkkönen, G. Michael Blackburn, R.G.G. Russell, Michael J. Rogers - Journal of Bone and Mineral Research 1997 cited by 440

  20. Human Osteoclast-Poor Osteopetrosis with Hypogammaglobulinemia due to TNFRSF11A (RANK) Mutations

    Authors: Matteo M. Guerrini, Cristina Sobacchi, Barbara Cassani, Mario Abinun, Sara Şebnem Kılıç, Alessandra Pangrazio, Daniele Moratto, Evelina Mazzolari, Jill Clayton‐Smith, Paul J. Orchard, Fraser P. Coxon, Miep Helfrich, Julie C. Crockett, David Mellis, Ashok Vellodi, İlhan Tezcan, Luigi D. Notarangelo, Michael J. Rogers, Paolo Vezzoni, Anna Villa, Annalisa Frattini - The American Journal of Human Genetics 2008 cited by 307

  21. Comparison of Atovaquone (566C80) with Trimethoprim-Sulfamethoxazole to Treat Pneumocystis carinii Pneumonia in Patients with AIDS

    Authors: Walter Hughes, Gifford Leoung, Françoise Kramer, Samuel A. Bozzette, Sharon Safrin, Peter Frame, Nathan Clumeck, Henry Masur, Danny J. Lancaster, Charles K. Chan, James P. Lavelle, Joel Rosenstock, Judith Falloon, Judith Feinberg, Stephen W. LaFon, Michael J. Rogers, Fred R. Sattler - New England Journal of Medicine 1993 cited by 306

  22. Recent advances in understanding the mechanism of action of bisphosphonates

    Authors: Fraser P. Coxon, Keith Thompson, Michael J. Rogers - Current Opinion in Pharmacology 2006 cited by 250

  23. Visualizing mineral binding and uptake of bisphosphonate by osteoclasts and non-resorbing cells

    Authors: Fraser P. Coxon, Keith Thompson, Anke J. Roelofs, Frank H. Ebetino, Michael J. Rogers - Bone 2008 cited by 238

  24. The molecular mechanism of action of the antiresorptive and antiinflammatory drug clodronate: Evidence for the formation in vivo of a metabolite that inhibits bone resorption and causes osteoclast and macrophage apoptosis

    Authors: Julie C. Frith, Jukka M�nkk�nen, Seppo Auriola, Hannu M�nkk�nen, Michael J. Rogers - Arthritis & Rheumatism 2001 cited by 267